A sleep aid composition based on biotransformation technology and its preparation method
By using microbial enzymatic transformation technology and a symbiotic fermentation system of Lactobacillus plantarum and Saccharomyces cerevisiae, macromolecular glycosides are degraded in a targeted manner to form small molecule aglycones that can easily cross the blood-brain barrier. This solves the problem of low absorption rate of natural plant extracts and achieves highly effective sleep aid and nerve repair.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TAIHAOLE BIOTECHNOLOGY CO LTD
- Filing Date
- 2026-06-02
- Publication Date
- 2026-06-30
AI Technical Summary
Existing natural plant extracts have problems such as low absorption rate and difficulty in crossing the blood-brain barrier in improving sleep, and traditional drug treatments for insomnia have problems such as drug resistance and difficulty in repairing neuronal damage.
Using microbial enzymatic transformation technology, a symbiotic fermentation system of Lactobacillus plantarum and Saccharomyces cerevisiae is used to directionally degrade macromolecular glycosides. Extracts of jujube seed, sea buckthorn, and raspberry are combined with GABA through biological matrix recombination to form small molecule aglycones that can easily cross the blood-brain barrier, thus synergistically exerting the drug effect.
It significantly improves the biopermeability and efficacy of active ingredients, promotes the biotransformation of central nervous system nutrients in the preparation of sleep-aiding compositions by prolonging the quality of slow-wave deep sleep, repairing central nervous system synaptic damage, extending the duration of slow-wave deep sleep, and improving sleep quality.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3